Title : Fingolimod ameliorates acetic acid-induced ulcerative colitis: An insight into its modulatory impact on pro/anti-inflammatory cytokines and AKT/mTOR signalling.

Pub. Date : 2022 May

PMID : 35274449






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Fingolimod ameliorates acetic acid-induced ulcerative colitis: An insight into its modulatory impact on pro/anti-inflammatory cytokines and AKT/mTOR signalling. Fingolimod Hydrochloride AKT serine/threonine kinase 1 Rattus norvegicus
2 BACKGROUND: Because of the approved immunomodulatory activities of fingolimod, the current study aimed at studying the curative potential of fingolimod against experimentally induced ulcerative colitis (UC) via modulating pro/anti-inflammatory cytokines release and AKT/mTOR signalling. Fingolimod Hydrochloride AKT serine/threonine kinase 1 Rattus norvegicus
3 In addition, fingolimod decreased the expressions of AKT and mTOR compared to the UC group. Fingolimod Hydrochloride AKT serine/threonine kinase 1 Rattus norvegicus
4 CONCLUSION: Fingolimod attenuated acetic acid-induced UC through its immunomodulatory effect by shifting the balance to favour anti-inflammatory cytokine production rather than pro-inflammatory cytokines and modulating the AKT/mTOR signalling. Fingolimod Hydrochloride AKT serine/threonine kinase 1 Rattus norvegicus